Literature DB >> 11925124

Laparoscopic retroperitoneal lymphadenectomy followed by immediate laparotomy in women with cervical cancer: a gynecologic oncology group study.

John B Schlaerth1, Nicola M Spirtos, Linda F Carson, Guy Boike, Thomas Adamec, Bette Stonebraker.   

Abstract

OBJECTIVES: From May 1993 until June 1997, the Gynecologic Oncology Group undertook a study of women with cancer of the cervix (Stage IA, IB, and IIA) who were about to undergo radical abdominal hysterectomy, pelvic lymphadenectomy, and aortic lymph node sampling. Immediately before this surgery, laparoscopy was performed and removal of the lymph nodes was attempted. There were two objectives: (1) to obtain information on the adverse effects and difficulties associated with laparoscopic lymph node removal and (2) to determine the adequacy of the lymph node removal.
METHODS: Four methods determined the adequacy of the lymph node removal: (1) the surgeon's opinion during laparoscopy, (2) a photographic record reviewed by two independent observers, (3) inspection of the surgical sites at laparotomy, and (4) lymph node count.
RESULTS: Seventy-three women were entered onto the study. Four patients were judged ineligible; 2 did not undergo laparoscopy and 17 women did not complete laparoscopic surgery because of metastatic lymph nodes judged unresectable or complications. Ten women were inevaluable. The remaining 40 women were completely evaluable for protocol objectives. All cases of bilateral laparoscopic aortic lymph node sampling were judged adequate by all four methods of evaluation. For laparoscopic pelvic lymphadenectomy 6 were judged incomplete at laparotomy, 3 of which were judged incomplete by independent reviewers. The mean number of right pelvic nodes removed was 16.6; left pelvic nodes 15.5; right aortic nodes 6.2; and left aortic nodes 5.9.
CONCLUSIONS: Laparoscopic bilateral aortic lymph node sampling appeared to be reasonably safe and feasible. Laparoscopic therapeutic bilateral pelvic lymphadenectomy, although having a reasonable complication rate, demonstrated problems regarding adequacy, which are probably correctable.

Entities:  

Mesh:

Year:  2002        PMID: 11925124     DOI: 10.1006/gyno.2001.6555

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  7 in total

1.  Laparoscopic surgery is a current tide of widely accepted standard procedure for endometrial cancer.

Authors:  Dong Hoon Suh; Jae Weon Kim
Journal:  J Gynecol Oncol       Date:  2010-06-30       Impact factor: 4.401

2.  Comparison of single-port laparoscopy and conventional laparoscopy for extraperitoneal para-aortic lymphadenectomy.

Authors:  Delphine Hudry; Francesco Cannone; Gilles Houvenaeghel; Max Buttarelli; Camille Jauffret; Elisabeth Chéreau; Eric Lambaudie
Journal:  Surg Endosc       Date:  2013-06-20       Impact factor: 4.584

Review 3.  Innovative laparoscopic surgery in gynecologic oncology.

Authors:  Siobhan M Kehoe; Pedro T Ramirez; Nadeem R Abu-Rustum
Journal:  Curr Oncol Rep       Date:  2007-11       Impact factor: 5.075

4.  Experiences of pretreatment laparoscopic surgical staging in patients with locally advanced cervical cancer: results of a prospective study.

Authors:  Myong Cheol Lim; Jaeman Bae; Jeong-Yoel Park; Soyi Lim; Sokbom Kang; Sang-Soo Seo; Joo-Yong Kim; Ju-Won Rho; Sang-Yoon Park
Journal:  J Gynecol Oncol       Date:  2008-06-20       Impact factor: 4.401

Review 5.  Transperitoneal laparoscopic pelvic and paraaortic lymphadenectomy in gynecologic cancers.

Authors:  Siobhan M Kehoe; Nadeem R Abu-Rustum
Journal:  Curr Treat Options Oncol       Date:  2006-03

6.  Videolaparoscopic radical hysterectomy approach: a ten-year experience.

Authors:  Luciana Silveira Campos; Leo Francisco Limberger; Antonio Nocchi Kalil; Gabriel Sebastião de Vargas; Paulo Agostinho Damiani; Fernanda Feltrin Haas
Journal:  JSLS       Date:  2009 Oct-Dec       Impact factor: 2.172

7.  Robotic-assisted transperitoneal aortic lymphadenectomy as part of staging procedure for gynaecological malignancies: single institution experience.

Authors:  V Zanagnolo; D Rollo; T Tomaselli; P G Rosenberg; L Bocciolone; F Landoni; G Aletti; M Peiretti; F Sanguineti; A Maggioni
Journal:  Obstet Gynecol Int       Date:  2013-08-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.